SK8312002A3 - Novel forms of pravastatin sodium - Google Patents
Novel forms of pravastatin sodium Download PDFInfo
- Publication number
- SK8312002A3 SK8312002A3 SK831-2002A SK8312002A SK8312002A3 SK 8312002 A3 SK8312002 A3 SK 8312002A3 SK 8312002 A SK8312002 A SK 8312002A SK 8312002 A3 SK8312002 A3 SK 8312002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- pravastatin sodium
- pravastatin
- solution
- crystalline
- solvent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17068599P | 1999-12-14 | 1999-12-14 | |
US19064900P | 2000-03-20 | 2000-03-20 | |
PCT/US2000/033867 WO2001043723A1 (en) | 1999-12-14 | 2000-12-14 | Novel forms of pravastatin sodium |
Publications (1)
Publication Number | Publication Date |
---|---|
SK8312002A3 true SK8312002A3 (en) | 2003-05-02 |
Family
ID=26866349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK831-2002A SK8312002A3 (en) | 1999-12-14 | 2000-12-14 | Novel forms of pravastatin sodium |
Country Status (15)
Country | Link |
---|---|
US (3) | US7001919B2 (xx) |
EP (1) | EP1242051A4 (xx) |
JP (2) | JP2003516959A (xx) |
KR (1) | KR20020062340A (xx) |
CN (1) | CN1434702A (xx) |
AU (1) | AU779306B2 (xx) |
CA (1) | CA2394200C (xx) |
CZ (1) | CZ20021998A3 (xx) |
HK (1) | HK1049441A1 (xx) |
HU (1) | HUP0204005A3 (xx) |
IL (1) | IL150187A0 (xx) |
PL (1) | PL364929A1 (xx) |
SK (1) | SK8312002A3 (xx) |
WO (1) | WO2001043723A1 (xx) |
YU (1) | YU45202A (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020062340A (ko) * | 1999-12-14 | 2002-07-25 | 비오갈 기오기스제르갸르 알티. | 신규 형태의 프라바스타틴 나트륨 |
WO2002092094A1 (fr) * | 2001-03-27 | 2002-11-21 | Sumitomo Pharmaceuticals Co., Ltd. | Derive d'isoxazole cristallin et preparation medicale associee |
US20080242725A1 (en) * | 2004-03-01 | 2008-10-02 | Janez Kerc | Pharmaceutical Composition |
WO2006017698A2 (en) | 2004-08-06 | 2006-02-16 | Transform Pharmaceuticals, Inc. | Novel statin pharmaceutical compositions and related methods of treatment |
EP1833780A1 (en) * | 2005-02-09 | 2007-09-19 | Teva Gyogyszergyár Zártköruen Muködo Részvenytarsaság | Methods of making pravastatin sodium |
JP4813841B2 (ja) * | 2005-07-25 | 2011-11-09 | キユーピー株式会社 | プラバスタチンナトリウムの製造方法 |
CN101648867B (zh) * | 2009-09-04 | 2012-07-11 | 天津大学 | 一种普伐他汀钠晶型及其制备方法和应用 |
EP2343054A1 (en) | 2010-01-04 | 2011-07-13 | LEK Pharmaceuticals d.d. | Pellets and microparticles of pravastatin sodium and a process of making them |
WO2012085191A1 (en) | 2010-12-23 | 2012-06-28 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Crystalline form of pravastatine and process for the preparation thereof |
MX2021001169A (es) | 2013-11-15 | 2023-02-10 | Akebia Therapeutics Inc | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas. |
CN105949062B (zh) * | 2016-06-24 | 2017-06-13 | 广东蓝宝制药有限公司 | 一种规模化制备普伐他汀钠d型晶体的工艺 |
CN111018714B (zh) * | 2019-12-27 | 2020-09-04 | 广东蓝宝制药有限公司 | 一种获得高纯a晶型普伐他汀钠的制备方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4319039A (en) | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
DK149080C (da) | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
DE3682557D1 (de) | 1985-09-13 | 1992-01-02 | Sankyo Co | Hydroxy-ml-236b-derivate, deren herstellung und anwendung. |
US4857547A (en) * | 1988-01-07 | 1989-08-15 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4857522A (en) * | 1988-03-21 | 1989-08-15 | E. R. Squibb & Sons, Inc. | Derivatives of pravastatin for inhibiting cholesterol biosynthesis |
US5180589A (en) | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
US5099035A (en) * | 1989-02-27 | 1992-03-24 | E. R. Squibb & Sons, Inc. | Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
US5140012A (en) | 1990-05-31 | 1992-08-18 | E. R. Squibb & Sons, Inc. | Method for preventing onset of restenosis after angioplasty employing pravastatin |
US5202029A (en) * | 1991-03-13 | 1993-04-13 | Caron Kabushiki Kaisha | Process for purification of hmg-coa reductase inhibitors |
US5157025A (en) | 1991-04-01 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug |
US5225202A (en) * | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
NZ250609A (en) | 1992-12-28 | 1995-07-26 | Sankyo Co | Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments |
SI9300303A (en) | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
IL112639A0 (en) | 1994-03-11 | 1995-05-26 | Bristol Myers Squibb Co | A pharmaceutical composition containing pravastin |
US5616595A (en) | 1995-06-07 | 1997-04-01 | Abbott Laboratories | Process for recovering water insoluble compounds from a fermentation broth |
US5942423A (en) * | 1995-06-07 | 1999-08-24 | Massachusetts Institute Of Technology | Conversion of compactin to pravastatin by actinomadura |
US5883109A (en) * | 1996-07-24 | 1999-03-16 | Bristol-Myers Squibb Company | Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug |
EP0975789A1 (en) | 1997-02-20 | 2000-02-02 | Dsm N.V. | Nitrogen feed in statin fermentation |
KR100210482B1 (ko) | 1997-04-10 | 1999-07-15 | 김종인 | 스트렙토마이세스엑스포리아투스(streptomycesexfoliatus)yj-118과이를이용한프라바스타틴나트륨의제조방법 |
WO1999010499A1 (en) | 1997-08-22 | 1999-03-04 | Dsm N.V. | Statin production by fermentation |
SI9800046A (sl) | 1998-02-18 | 1999-08-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti |
SI20072A (sl) | 1998-09-18 | 2000-04-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze |
SI20305A (sl) | 1999-08-06 | 2001-02-28 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristali natrijeve soli pravastatina |
WO2000033821A1 (en) * | 1998-12-07 | 2000-06-15 | Bristol-Myers Squibb Company | Enteric coated pravastatin bead formulation |
US6682913B1 (en) | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
CA2361701C (en) | 1999-02-03 | 2007-04-10 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
HUP9902352A1 (hu) | 1999-07-12 | 2000-09-28 | Gyógyszerkutató Intézet Kft. | Eljárás pravasztatin mikrobiológiai előállítására |
US6444452B1 (en) | 1999-11-30 | 2002-09-03 | Biogal Gyogyszergyar Rt. | Process for recovering statin compounds from a fermentation broth |
KR20020062340A (ko) * | 1999-12-14 | 2002-07-25 | 비오갈 기오기스제르갸르 알티. | 신규 형태의 프라바스타틴 나트륨 |
CA2422744A1 (en) | 2000-10-05 | 2002-04-18 | Biogal Gyogyszergyar Rt. | Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
DE10209305A1 (de) | 2001-04-30 | 2002-10-31 | Basf Ag | Thermische Spaltung von Allophanaten |
-
2000
- 2000-12-14 KR KR1020027007610A patent/KR20020062340A/ko not_active IP Right Cessation
- 2000-12-14 EP EP00984355A patent/EP1242051A4/en not_active Withdrawn
- 2000-12-14 US US09/736,796 patent/US7001919B2/en not_active Expired - Fee Related
- 2000-12-14 CN CN00818961A patent/CN1434702A/zh active Pending
- 2000-12-14 AU AU20987/01A patent/AU779306B2/en not_active Ceased
- 2000-12-14 YU YU45202A patent/YU45202A/sh unknown
- 2000-12-14 WO PCT/US2000/033867 patent/WO2001043723A1/en not_active Application Discontinuation
- 2000-12-14 CZ CZ20021998A patent/CZ20021998A3/cs unknown
- 2000-12-14 IL IL15018700A patent/IL150187A0/xx unknown
- 2000-12-14 SK SK831-2002A patent/SK8312002A3/sk unknown
- 2000-12-14 CA CA002394200A patent/CA2394200C/en not_active Expired - Fee Related
- 2000-12-14 PL PL00364929A patent/PL364929A1/xx unknown
- 2000-12-14 JP JP2001544662A patent/JP2003516959A/ja active Pending
- 2000-12-14 HU HU0204005A patent/HUP0204005A3/hu unknown
-
2003
- 2003-03-03 HK HK03101565.0A patent/HK1049441A1/zh unknown
-
2004
- 2004-12-01 JP JP2004349020A patent/JP2005120105A/ja active Pending
-
2005
- 2005-08-09 US US11/200,794 patent/US7262218B2/en not_active Expired - Fee Related
-
2007
- 2007-04-03 US US11/730,639 patent/US20070197633A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
YU45202A (sh) | 2005-11-28 |
US20010041809A1 (en) | 2001-11-15 |
HUP0204005A3 (en) | 2003-05-28 |
JP2005120105A (ja) | 2005-05-12 |
JP2003516959A (ja) | 2003-05-20 |
AU2098701A (en) | 2001-06-25 |
AU779306B2 (en) | 2005-01-13 |
KR20020062340A (ko) | 2002-07-25 |
US7262218B2 (en) | 2007-08-28 |
IL150187A0 (en) | 2002-12-01 |
CA2394200A1 (en) | 2001-06-21 |
CA2394200C (en) | 2006-10-03 |
US20050288370A1 (en) | 2005-12-29 |
CN1434702A (zh) | 2003-08-06 |
HUP0204005A2 (hu) | 2003-03-28 |
EP1242051A4 (en) | 2004-05-12 |
CZ20021998A3 (cs) | 2003-02-12 |
WO2001043723A1 (en) | 2001-06-21 |
US20070197633A1 (en) | 2007-08-23 |
EP1242051A1 (en) | 2002-09-25 |
PL364929A1 (en) | 2004-12-27 |
HK1049441A1 (zh) | 2003-05-16 |
US7001919B2 (en) | 2006-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7262218B2 (en) | Forms of pravastatin sodium | |
JP6359971B2 (ja) | イバブラジン塩酸塩の形態iv | |
EP0907639B1 (en) | Polymorphic compounds | |
US20050192236A1 (en) | Crystaline clindamycin free base | |
KR20220017932A (ko) | 타파미디스 및 그 염의 고상형 | |
NO312513B1 (no) | Mesylat-trihydrat av 5-(2-(4-(1,2-benzoisotiazol-3-yl)-1- piperazinyl)-etyl)-6-klor-1,3-dihydro-2H-indol-2-on(=ziperasidone), og farmasöytisk blanding for behandling avpsykotisk forstyrrelse | |
JP2006249105A (ja) | ゾルピデムヘミタートレイト | |
WO2020185812A1 (en) | Solid state forms of ripretinib | |
EA028769B1 (ru) | Фармацевтические композиции, содержащие рифаксимин и аминокислоты, способ их получения и их применение | |
WO2023064519A1 (en) | Solid state forms of elacestrant and processes for preparation thereof | |
AU2011334928A1 (en) | Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size | |
JP2023509242A (ja) | 新規なエンパグリフロジンの共結晶 | |
EP2601175A1 (en) | A novel crystalline compound comprising saxagliptin and phosphoric acid | |
KR20040086397A (ko) | 아토르바스타틴 헤미-칼슘 용매화합물의 탈용매화 | |
CN108239055B (zh) | 一种thr1442 l-天冬氨酸共晶、其制备方法及药物组合物 | |
EP4433461A1 (en) | Solid state form of tafamidis | |
WO2021119223A1 (en) | Solid state form of lemborexant | |
EP1523978A2 (en) | Crystalline forms of pravastatin sodium | |
CA2551203A1 (en) | Novel forms of pravastatin sodium | |
WO2020154581A1 (en) | Solid state forms of fedovapagon-salicyclic acid co-crystal | |
WO2023287938A1 (en) | Solid state forms of amcenestrant | |
KR20230087557A (ko) | 로레시비빈트의 고상형 | |
WO2024121805A1 (en) | Solid state forms of zipalertinib and process for preparation thereof | |
JPH08231510A (ja) | 新規光学活性アミノピリジン誘導体結晶、その製法および用途 |